Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
- Country:
- France
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
UAE and French Presidents discuss bilateral relations and latest regional and international developments
Science News Roundup: Fossils of colossal snake Vasuki unearthed in India mine; Gigantic marine reptile's fossils found by British girl and father and more
Tennis-Former Wimbledon and French Open champion Muguruza retires
Russian foreign ministry: U.S. aid to Ukraine, Israel, Taiwan will deepen crises
Russia says deeper U.S. hybrid war using Ukraine will end in Vietnam-style humiliation